Weight Watchers Files for Bankruptcy as Weight-Loss Drugs Disrupt Diet Industry
Facing financial strain from competition with weight-loss drugs like Ozempic, WW International (formerly WeightWatchers) filed for Chapter 11 bankruptcy protection. This move aims to eliminate $1.15 billion in debt and restructure for future growth, allowing the company to reinvest in its members and innovate within the evolving weight management market. The reorganization is expected to be completed within 40 days, with no disruption to existing members. The company’s acquisition of telehealth provider Sequence reflects its strategic shift towards incorporating weight-loss medications into its services.
John Q. Hosedrinker